Boston Sci, Stryker Prevail In Long-Running Suits

Two closely watched device-world intellectual property cases moved toward a conclusion last week, as Boston Scientific triumphed over Edwards in a TAVR suit and Zimmer was ordered to pay $254m for infringing Stryker’s patent on a surgical-cleaning wand.

Gavel_1200x675

December has been a busy month for device industry patent law, with two major cases moving closer to a resolution in recent days.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legal & IP

More from Policy & Regulation

Medtech Seeks Inclusion In EU’s Groundbreaking Life Sciences Strategy

 

As the EU Life Sciences Strategy aims to drive innovation, the medtech sector is pushing for a pivotal role in a mission intended to embrace green and digital transitions, address regulatory obstacles and reduce dependency on external sources.

Former FDA Head Tells Heart Society To ‘Get Involved’ To Protect Health Innovation

 
• By 

Former FDA Commissioner Robert Califf urged the Heart Rhythm Society to engage actively amid federal funding cuts. He highlighted collaboration among researchers, advocates for healthcare integration, and the importance of addressing social determinants of health, while discussing lobbying strategies and the challenges faced by medtech companies.

Q’Apel Medical Recalls, Discontinues Stroke Therapy System After FDA Warning Letter, Class I Designation

 

Q’Apel Medical has pulled its aspiration system for stroke thrombectomy from the market after concerns raised by the US FDA in a February warning letter.